Browse > Article
http://dx.doi.org/10.22246/jikm.2021.42.5.846

A Case Report on Korean Medical Treatment of a Patient with Abnormal Liver Function Induced by Rovazet  

Kang, Hee-kyung (Dept. of Internal Medicine, Korean Medicine Hospital, Pusan National University)
Cho, Im-hak (Dept. of Internal Medicine, Korean Medicine Hospital, Pusan National University)
Lee, Chan (Dept. of Internal Medicine, Korean Medicine Hospital, Pusan National University)
Heo, Gi-yoon (Dept. of Internal Medicine, Korean Medicine Hospital, Pusan National University)
Kim, Min-hwa (Dept. of Internal Medicine, Korean Medicine Hospital, Pusan National University)
Kwon, Jung-nam (Dept. of Internal Medicine, Korean Medicine Hospital, Pusan National University)
Kim, So-yeon (Dept. of Internal Medicine, Korean Medicine Hospital, Pusan National University)
Park, Seong-ha (Dept. of Internal Medicine, Korean Medicine Hospital, Pusan National University)
Yun, Young-ju (Dept. of Internal Medicine, Korean Medicine Hospital, Pusan National University)
Lee, In (Dept. of Internal Medicine, Korean Medicine Hospital, Pusan National University)
Choi, Jun-yong (Dept. of Internal Medicine, Korean Medicine Hospital, Pusan National University)
Hong, Jin-woo (Dept. of Internal Medicine, Korean Medicine Hospital, Pusan National University)
Han, Chang-woo (Dept. of Internal Medicine, Korean Medicine Hospital, Pusan National University)
Publication Information
The Journal of Internal Korean Medicine / v.42, no.5, 2021 , pp. 846-852 More about this Journal
Abstract
Objective: This study evaluated a clinical case of a patient with Rovazet-induced abnormal liver function treated with intradermal acupuncture. Method: A 59-year-old woman with abnormal liver function induced by Rovazet ceased taking the drug and instead received intradermal acupuncture treatment. After 15 days, clinical symptoms and laboratory test results were evaluated. Results: Aspartate aminotransferase and alanine aminotransferase levels decreased, and clinical symptoms such as nausea and fatigue improved after treatment with intradermal acupuncture and cessation of the Rovazet. Conclusion: This study meaningfully examined a clinical case of a patient with abnormal liver function induced by a lipid-lowering agent, which is uncommon in Korea. Unfortunately, the lack of clear evidence and the use of only one case are limitations of the study.
Keywords
rovazet; abnormal liver function; Korean medicinal treatment; case report;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Bjornsson ES. Epidemiology, predisposing factors, and outcomes of drug-induced liver injury. Clin Liver Dis 2020;24(1):1-10   DOI
2 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: drug-induced liver injury. J Hepatol 2019;70(6):1222-61.   DOI
3 An SY, Joo SH, Hur SY, Jang EG, Lee JH, Kim YC. A case report of efficacy of saenggan-tang on a patient with drug induced liver injury. J Int Korean Med 2019;40(2):201-7.   DOI
4 Son CG. A Drug-Induced Liver Injury by Western Medication. J Int Korean Med 2015;36(1):69-75.   DOI
5 Kim JY. Disease of digestive system. Seoul: ilchokak; 2016, p. 741-5.
6 Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs-II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 1993;46(11):1331-6.   DOI
7 Davidson MH, Ballantyne CM, Kerzner B, Melani L, Sager PT, Lipka L, et al. Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia. Int J Clin Pract 2002;58(8):746-55.   DOI
8 Low EXS, Zheng Q, Chan E, Lim SG. Drug induced liver injury: East versus west. a systematic review and meta-analysis. Clinical and Molecular Hepatology 2020;26(2):142-54.   DOI
9 Dev K. Drug-induced liver injury. Clin Med 2016;16(6):104-9.
10 Lee BR, Kim WI. A case report of the effect of korean medicine on liver function test of drug-induced liver injury patient treated with western medicine. Official Journal of The Korean Medicine Society For The Herbal Formula Study 2014;22(1):193-200.
11 Kim JH, Cho JH, Son CG. A case report for a toxic liver injury caused by voluntary administration of smilacis chinae radix. Korean J Orient Int Med 2012;33(4):609-14.
12 Park SJ, Lee HM, Kang YK, Jeon SH, Kim JW. A case study of herbal medicine-induced liver injury improved with taeumjowe-tang(taiyintiaowei-tang). Journal of Sasang Constitutional Medicine 2010;22(2):135-42.
13 Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison's principles medicine. 19th edition. New York: McGraw-Hill; 2015, p. 2897-99.
14 Aida OA, Camilla S, M.Isabel L, Raul JA. Case characterization, clinical features and risk factors in drug-induced liver injury. Int J Mol Sci 2016;17(5):714.   DOI
15 경락경혈학 교재편찬위원회. 대한경락경혈학 제7판. 대전: 종려나무; 2016, p. 353-485.
16 Yvette NL. Rosuvastatin/ezetimibe: a review in hypercholesterolemia. Am J Cardiovasc Drugs 2020;20(4):381-92.   DOI
17 Ballantyne CM. Ezetimibe: efficacy and safety in clinical trials. Eur Heart J Suppl 2002;4 (Supplement J):J9-J18.   DOI
18 Shin WJ, Kim TY, Park YJ, Moon JH, Ko H, Kim GT, et al. One case of drug-induced liver injury after taking gamiyukgunja-tang. Korean J Orient Int Med 2011;32(3):444-50.
19 Ammar H, Rober JF. The diagnosis and management of idiosyncratic drug-induced liver injury. Liver Int 2019;39(1):31-41.   DOI